Literature DB >> 3968639

Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in conscious rats at rest and during treadmill exercise.

H Drexler, S F Flaim, R H Fields, R Zelis.   

Abstract

This study examined the effects of the dihydropyridine derivative nisoldipine (1.6 micrograms/kg/min) on hemodynamics and regional blood flow (radioactive microspheres, 15 +/- 5 microns) in conscious rats at rest and during treadmill exercises (35 feet/min, 5 min). Nisoldipine significantly reduced systemic vascular resistance (-38%) and mean arterial pressure (-17%) and increased heart rate (P less than .05). Skeletal muscle blood flow was increased and vascular resistances in the skeletal muscle, in renal and coronary arteries and in part of the gut circulations were significantly reduced (all P less than .05). Left ventricular end-diastolic pressure was unchanged by the drug both at rest and during exercise. At exercise, nisoldipine significantly increased skeletal muscle blood flow in four of eight skeletal muscle regions investigated; however, the increase in total skeletal muscle flow was less pronounced compared to the changes at rest. The vasodilator effect of nisoldipine in the renal and splanchnic circulations was markedly attenuated by the exercise-induced vasoconstriction in these circulatory beds. We conclude that nisoldipine is a potent vasodilator of skeletal muscle and coronary and renal arteries. It appears to possess highly selective effects on vascular smooth muscle as compared to its direct cardiac effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968639

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

2.  Nicorandil and cardiovascular performance in anaesthetized pigs with a concentric coronary artery stenosis.

Authors:  L M Sassen; L K Soei; T J Heere; L J van Woerkens; P R Saxena; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

3.  [Calcium antagonists in heart failure?].

Authors:  H Drexler; H Just
Journal:  Klin Wochenschr       Date:  1986-10-15

Review 4.  The pharmacology of nisoldipine.

Authors:  A Knorr
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

5.  The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.

Authors:  J van Harten; P van Brummelen; R R Zeegers; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

6.  The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.

Authors:  D J Duncker; J M Hartog; P G Hugenholtz; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.